Arkin Holdings strives to combine the vision of answering unmet healthcare needs, while skillfully managing investor equity, outperforming benchmarks and generating long-term returns. We design unique investment tools and platforms, to fund innovative companies that develop groundbreaking drugs and products – all while managing investment risks, supporting portfolio companies and ensuring value creation.
PHARMA AND BIOTECH
Arkin Bio Ventures continuously searches for companies that develop pharmaceutical and biotechnology products with a clear innovative edge.
Accelmed integrates commercial platforms with innovation, providing growth equity to foster significant value creation in the field of medical device development.
Sol-Gel develops topical dermatology products that enhance treatment tolerability and effectiveness - resulting in increased patient compliance.
Sphera Global Healthcare invests in publicly traded healthcare companies, while generating long-term returns that consistently outperform relevant benchmarks, on a risk-adjusted basis.